Legal Representation
Attorney
Anne H. Peck
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 10, 2013 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 10, 2013 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Nov 12, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 12, 2012 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 12, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 4, 2012 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 20, 2012 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Jul 19, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 16, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of two stylized lines that converge at top at the narrowest point after the word KYPROLIS.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042